# An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder

> **NCT00330655** · PHASE4 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 15 (actual)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** memantine

## Key facts

- **NCT ID:** NCT00330655
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2007-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330655, "An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00330655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*